These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2984267)
21. beta-Adrenergic receptors and adenylate cyclase activity in murine lymphoid cell lines. Staehelin M; Müller P; Portenier M; Harris AW J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):55-64. PubMed ID: 2984265 [TBL] [Abstract][Full Text] [Related]
22. Homologous desensitization of beta-adrenergic receptors in lymphoma cells is not altered by the inactivation of Ni (Gi), the inhibitory guanine nucleotide regulatory protein. Clark RB; Goka TJ; Proll MA; Friedman J Biochem J; 1986 Apr; 235(2):399-405. PubMed ID: 3017303 [TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of S49 lymphoma cells deficient in beta-adrenergic receptors: relation of receptor number to activation of adenylate cyclase. Johnson GL; Bourne HR; Gleason MK; Coffino P; Insel PA; Melmon KL Mol Pharmacol; 1979 Jan; 15(1):16-27. PubMed ID: 34089 [No Abstract] [Full Text] [Related]
24. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells. Barovsky K; Pedone C; Brooker G Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948 [TBL] [Abstract][Full Text] [Related]
25. Effects of agonist and phorbol ester on adrenergic receptors of DDT1 MF-2 cells. Cowlen MS; Toews ML J Pharmacol Exp Ther; 1987 Nov; 243(2):527-33. PubMed ID: 2824749 [TBL] [Abstract][Full Text] [Related]
26. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response. Mahan LC; Insel PA Mol Pharmacol; 1986 Jan; 29(1):16-22. PubMed ID: 3003560 [TBL] [Abstract][Full Text] [Related]
27. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system. Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901 [TBL] [Abstract][Full Text] [Related]
28. Forskolin binding to intact S49 lymphoma cells. Barber R Second Messengers Phosphoproteins; 1988; 12(1):59-71. PubMed ID: 3193376 [TBL] [Abstract][Full Text] [Related]
29. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist. Scarpace PJ; Abrass IB J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402 [TBL] [Abstract][Full Text] [Related]
30. Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha. Böhm M; Schmidt U; Gierschik P; Schwinger RH; Böhm S; Erdmann E Mol Pharmacol; 1994 Mar; 45(3):380-9. PubMed ID: 8145725 [TBL] [Abstract][Full Text] [Related]
31. Uncoupling of the beta-adrenergic receptor as a mechanism of in vitro neutrophil desensitization. Galant SP; Britt S J Lab Clin Med; 1984 Feb; 103(2):322-32. PubMed ID: 6319518 [TBL] [Abstract][Full Text] [Related]
32. Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells. Clark RB; Kunkel MW; Friedman J; Goka TJ; Johnson JA Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1442-6. PubMed ID: 2830619 [TBL] [Abstract][Full Text] [Related]
33. Adenylate cyclase activity as a function of forskolin concentration. Barber R; Goka TJ J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):23-9. PubMed ID: 2984262 [TBL] [Abstract][Full Text] [Related]
34. Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators. Cowlen MS; Toews ML Mol Pharmacol; 1988 Sep; 34(3):340-6. PubMed ID: 2901664 [TBL] [Abstract][Full Text] [Related]
35. [Isolation, purification and characterization of regulatory properties of adenylate cyclase from rabbit heart]. Tkachuk VA; Baldenkov GN Biokhimiia; 1978 Jun; 43(6):1097-110. PubMed ID: 27249 [TBL] [Abstract][Full Text] [Related]
36. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model. Stickle D; Barber R Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693 [TBL] [Abstract][Full Text] [Related]
37. Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Laurenza A; Khandelwal Y; De Souza NJ; Rupp RH; Metzger H; Seamon KB Mol Pharmacol; 1987 Jul; 32(1):133-9. PubMed ID: 3600614 [TBL] [Abstract][Full Text] [Related]
38. Agonist regulation of beta-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants. Hadcock JR; Ros M; Malbon CC J Biol Chem; 1989 Aug; 264(23):13956-61. PubMed ID: 2547776 [TBL] [Abstract][Full Text] [Related]
39. Time-dependent decreases in binding affinity of agonists for beta-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization. Insel PA; Mahan LC; Motulsky HJ; Stoolman LM; Koachman AM J Biol Chem; 1983 Nov; 258(22):13597-605. PubMed ID: 6315705 [TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of beta-adrenergic receptor internalization and down-regulation. Mahan LC; Koachman AM; Insel PA Proc Natl Acad Sci U S A; 1985 Jan; 82(1):129-33. PubMed ID: 2982140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]